Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel lloperidone pharmaceutical co-crystal and preparation method thereof

A technology of iloperidone and drugs, applied in the field of new iloperidone drug co-crystal and its preparation, to achieve the effect of improving bioavailability and stability

Inactive Publication Date: 2012-09-12
吉林三善恩科技开发有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Drug crystal form research and solid-state characterization of drugs are relatively mature and highly valued fields in the European and American pharmaceutical industry, but they are still in their infancy in the domestic pharmaceutical industry

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel lloperidone pharmaceutical co-crystal and preparation method thereof
  • Novel lloperidone pharmaceutical co-crystal and preparation method thereof
  • Novel lloperidone pharmaceutical co-crystal and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Synthesis of co-crystals using iloperidone and 2,3-dihydroxybenzoic acid:

[0030] Weighing:

[0031] The reactants are fed according to the mass ratio of iloperidone:2,3-dihydroxybenzoic acid=1:1. Accurately weigh 20.00 mg of iloperidone and 20.00 mg of 2,3-dihydroxybenzoic acid with an analytical balance.

[0032] Dissolution of API:

[0033] Use a 5ml pipette to accurately measure 5ml of ethanol into a 25ml single-necked round bottom flask.

[0034] Reflux-volatilization heat method:

[0035] Put the magnetic stirrer in the round-bottomed flask of the above-mentioned weighed uniformly dissolved medicine, set up the reflux device, the reflux time is 2h, the reflux temperature is 90°C, and the magnetic stirrer and condensed water are turned on.

[0036] After reflux, the reaction solution was filtered, and the filtrate was placed in a 25ml transparent glass vial, and after 6 hours of slow volatilization of the solvent, transparent massive crystals were formed, and th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of pharmaceutical co-crystals, in particular to a novel lloperidone pharmaceutical co-crystal and a preparation method thereof. The pharmaceutical co-crystal takes lloperidone as an active pharmaceutical ingredient and takes 2, 3-dihydroxy-benzoic acid as a precursor; one lloperidone molecule, one 2, 3-dihydroxy-benzoic acid molecule and one water molecule commonly form a basic structural unit of the lloperidone pharmaceutical co-crystal under the hydrogen bond and accumulation actions. A solvent selected by the pharmaceutical co-crystal is ethanol and is prepared by adopting a backflow-diffused evaporation method; and as the selected organic solvent is lower in boiling point, the crystal is crystallized out in the solvent evaporation process after backflow filtering. The pharmaceutical co-crystal prepared by the invention not only inherits the characteristic of traditional raw medicine in treating schizophrenia, but also is remarkably improved on dissolubility, stability and bioavailability of the pharmaceutical co-crystal.

Description

technical field [0001] The invention belongs to the technical field of drug co-crystals, and in particular relates to a novel iloperidone drug co-crystal and a preparation method thereof. Background technique [0002] In 1894, E. Fischer of Germany proposed the "lock-key" model based on the idea of ​​"selective interaction between molecules", which was the prototype of modern supramolecular science theory. In 1937, German K.L.Wolf et al. created the term "supramolecular" to describe highly ordered entities formed by the association of molecules. In a general sense, any collection of molecules has interactions, so people often refer to them as The structural level of matter aggregation state is called "supramolecular". It was not until 1978 that Professor J.M.Lehn of France finally proposed the complete concept of "supramolecular chemistry" based on the traditional research on the host-guest system rooted in organic chemistry. Supramolecular chemistry is a science that stud...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D413/04
Inventor 张婷婷赵晓君罗亚楠刘磊韩冰朱广山
Owner 吉林三善恩科技开发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products